Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04827732 · ClinicalTrials.gov registry record · NA
Hypofractionated Pencil-Beam Scanning Intensity-modulated Proton Therapy (IMPT) in Recurrent Rectal Cancer
A NA study, sponsored by Washington University School of Medicine.
- Terminated
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT04827732 is a NA study that was terminated before completion, run by Washington University School of Medicine. The registered enrollment target is 15 participants.
The verdict
NCT04827732, a NA study, was terminated before completion, sponsored by Washington University School of Medicine.
- TERMINATED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
The purpose of this trial is to determine the maximum tolerated dose (MTD) of hypofractionated IMPT for the reirradiation of locoregionally recurrent rectal cancer.
Interventions
- RADIATION Hypofractionated Pencil-Beam Scanning Intensity-modulated Proton Therapy
- DEVICE MEVION S250i Hyperscan and Adaptive Aperture Proton Therapy Machine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2021-05-04 |
| Est. Completion | 2024-11-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04827732
The ClinicalTrials.gov registry entry for NCT04827732 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Hypofractionated Pencil-Beam Scanning Intensity-modulated Proton Therapy is the first listed.
NCT04827732 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04827732 about?
NCT04827732 is a clinical study titled "Hypofractionated Pencil-Beam Scanning Intensity-modulated Proton Therapy (IMPT) in Recurrent Rectal Cancer". The purpose of this trial is to determine the maximum tolerated dose (MTD) of hypofractionated IMPT for the reirradiation of locoregionally recurrent rectal cancer.
What is the current status of trial NCT04827732?
This trial is currently terminated. It is a NA study. The enrollment target is 15 participants. The study started on 2021-05-04. Estimated completion is 2024-11-18.
What interventions are being tested in trial NCT04827732?
The interventions under investigation include: Hypofractionated Pencil-Beam Scanning Intensity-modulated Proton Therapy (RADIATION), MEVION S250i Hyperscan and Adaptive Aperture Proton Therapy Machine (DEVICE).
Who is sponsoring clinical trial NCT04827732?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.